One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer

World Journal of Gastroenterology

Volumn 11, Issue 23, 2005, Pages 3566-3569

  Mesquita, Maria Aparecida ^a   Silva Lorena, Sônia Letícia ^a   Souza Almeida, Jazon Romilson ^a   Garcia Montes, Ciro ^a   Guerrazzi, Fábio ^a   Campos, Luciana T ^a   Rubiota Zeitune, José Murilo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Clarithromycin; Helicobacter pylori; Peptic ulcer; Ranitidine bismuth citrate

Indexed keywords

CLARITHROMYCIN; RANITIDINE BISMUTH CITRATE; UREASE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRAZIL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; STOMACH ULCER; TASTE DISORDER;

EID: 21344437304     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i23.3566     Document Type: Article

References (23)

1. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc committee on practice parameters of the american college of gastroenterology. Am J Gastroenterol 1998; 93: 2330-2338
2. Treiber G, Lambert JR. The impact of Helicobacter pylori eradication on peptic ulcer healing. Am J Gastroenterol 1998; 93: 1080-1084
3. Malfertheiner P, Megraud F, O'Morain C, Bell D, Bianchi Porro G, Deltenre M, Forman D, Gasbarrini G, Jaup B, Misiewicz JJ, Pajares J, Quina M, Rauws E. Current European concepts in the management of Helicobacter pylori infection- the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997; 9: 1-2
4. de Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BMJ 2000; 320: 31-34
5. de Boer WA, Haeck PW, Otten MH, Mulder C. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-d triple therapies and a 14-d dual therapy. Am J Gastroenterol 1998; 93: 1101-1107
6. Williamson R, Pipkin GA, Wood JR. New options in Helicobacter pylori eradication: efficacy, resistance and synergy. Scand J Gastroenterol Suppl 1998; 225: 36-40
7. Kamberoglou D, Polymeros D, Sanidas I, Dougerouglou V, Savva S, Patra E, Tzias V. Comparison of 1-wk vs 2- or 4-weeh therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001; 15: 1493-1497
8. Van der Wouden EJ, Thijs JC, van Zwet AA, Kooy A, Kleibeuker J. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two- week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. Am J Gastroenterol 1998; 93: 1228-1231
9. Hoffman JS, Katz LM, Cave DR. Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. Aliment Pharmacol Ther 1999; 3: 503-506
10. Pozzato P, Zagari M, Cardelli A, Catalano FA, Giglio A, Lami F, Pilotto A, Scarpulla G, Spadaccini A, Susi D, Tosatto R, Olivieri A, Bazzoli F, Roda E. Ranitidine bismuth citrate plus clarithromycin 7-d regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 447-451
11. Pipkin GA, Dixon JS, Williamson R, Wood JR. Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review. Helicobacter 1997; 2: 159-171
12. Mendonça S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, Pedrazzoli J Jr. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and furazolidone in Brazil. Helicobacter 2000; 5: 79-83
13. Prazeres Magalhães P, de Magalhães Queiroz DM, Campos Barbosa DV, Aguiar Rocha G, Nogueira Mendes E, Santos A, Valle Correa PR, Camargo Rocha AM, Martins Teixeira L, Affonso de Oliveira C. Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil. Antimicrob Agents Chemoter 2002; 46: 2021-2023
14. Ecclissato C, Marchioretto MA, Mendonça S, Godoy AP, Guersoni RA, Degger M, Piovesan H, Ferraz JG, Pedrazzoli J. Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication. Helicobacter 2002; 7: 53-59
15. Mégraud F, Roberts P, Williamson R. Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo. Helicobacter 2000; 5: 222-226
16. Bardhan KD, Morton D, Perry MJ, Sanders DS, Morris P, Rowland A, Thompson M, Mitchell TR, Roberts PM. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 2001; 15: 1199-1204
17. Veldhuyzen van Zanten S, Chiba N, Barkun A, Fallone C, Farley A, Cockeram A, Dallaire C, Simms L, Nicholls B. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. Can J Gastroenterol 2003; 17: 533-538
18. Eisig JN, Silva FM, Hashimoto C, Chehter EZ, Laudanna AA. Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients. São Paulo Med J 2003; 121: 15-18
19. Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther 2003; 17: 297-305
20. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-1447
21. Fallone C, Barkun A. Friedman: Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95: 914-920
22. Hamada H, Haruma K, Mihara M, Kamada T, Yoshihara Sumii K, Kajiyama G, Kawanishi M. High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14: 729-735
23. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002; 97: 2992-2997